| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |